Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
Saletu-Zyhlarz G, Anderer P, Gruber G, Mandl M, Gruber D, Metka M, Huber J, Oettel M, Gräser T, Abu-Bakr MH, Grätzhofer E, Saletu B. Saletu-Zyhlarz G, et al. Among authors: huber j. J Sleep Res. 2003 Sep;12(3):239-54. doi: 10.1046/j.1365-2869.2003.00356.x. J Sleep Res. 2003. PMID: 12941063 Clinical Trial.
Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
Anderer P, Saletu B, Saletu-Zyhlarz G, Gruber D, Metka M, Huber J, Pascual-Marqui RD. Anderer P, et al. Among authors: huber j. Neuropsychobiology. 2004;49(3):134-53. doi: 10.1159/000076722. Neuropsychobiology. 2004. PMID: 15034229 Clinical Trial.
Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
Linzmayer L, Semlitsch HV, Saletu B, Böck G, Saletu-Zyhlarz G, Zoghlami A, Gruber D, Metka M, Huber J, Oettel M, Gräser T, Grünberger J. Linzmayer L, et al. Among authors: huber j. Arzneimittelforschung. 2001;51(3):238-45. doi: 10.1055/s-0031-1300030. Arzneimittelforschung. 2001. PMID: 11304940 Clinical Trial.
Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls.
Saletu B, Brandstätter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, Heytmanek G, Huber J, Grünberger J, Linzmayer L, Kurz C, Decker K, Binder G, Knogler W, Koll B. Saletu B, et al. Among authors: huber j. Maturitas. 1996 Feb;23(1):91-105. doi: 10.1016/0378-5122(95)00946-9. Maturitas. 1996. PMID: 8861091 Clinical Trial.
Hormone replacement therapy and intraocular pressure.
Sator MO, Joura EA, Frigo P, Kurz C, Metka M, Hommer A, Huber JC. Sator MO, et al. Among authors: huber jc. Maturitas. 1997 Sep;28(1):55-8. doi: 10.1016/s0378-5122(97)00060-1. Maturitas. 1997. PMID: 9391995
2,101 results